We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The National Amyotrophic Lateral Sclerosis Registry

This study is currently recruiting participants.
Verified July 2015 by Centers for Disease Control and Prevention
Sponsor:
ClinicalTrials.gov Identifier:
NCT01772602
First Posted: January 21, 2013
Last Update Posted: August 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
VA Office of Research and Development
Centers for Medicare and Medicaid Services
Information provided by (Responsible Party):
Centers for Disease Control and Prevention
January 17, 2013
January 21, 2013
August 9, 2016
October 2010
December 2020   (Final data collection date for primary outcome measure)
The National Amyotrophic Lateral Sclerosis (ALS) Registry [ Time Frame: 1 year ]
To determine the incidence and prevalence of Amyotrophic Lateral Sclerosis in the US.
The National Amyotrophic Lateral Sclerosis (ALS) Registry [ Time Frame: ongoing ]
To determine the incidence and prevalence of Amyotrophic Lateral Sclerosis in the US.
Complete list of historical versions of study NCT01772602 on ClinicalTrials.gov Archive Site
Risk factors of ALS [ Time Frame: 1 year ]
To learn more about the potential risk factors for ALS
Not Provided
Not Provided
Not Provided
 
The National Amyotrophic Lateral Sclerosis Registry
The National Amyotrophic Lateral Sclerosis Registry
The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.
Not Provided
Observational [Patient Registry]
Not Provided
5 Years
Not Provided
Non-Probability Sample
ALS cases in the United States
Amyotrophic Lateral Sclerosis
Not Provided
Not Provided
Not Provided
 
Recruiting
13000
December 2020
December 2020   (Final data collection date for primary outcome measure)

Inclusion Criteria:

- U.S. citizens 18 years of age or older

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact: Paul Mehta, MD 770-488-0556 PMehta1@cdc.gov
Contact: Kevin Horton, DrPH, MSPH 770-488-1555 dhorton@cdc.gov
United States
 
 
NCT01772602
CDC-NCEH/ATSDR-5768
No
Not Provided
Not Provided
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
  • VA Office of Research and Development
  • Centers for Medicare and Medicaid Services
Principal Investigator: Paul Mehta, MD Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
July 2015